Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Study exposes lack of diversity in US cancer trials

NHS England reveals travel plan to cut waiting lists

GSK hepatitis B hope bepirovirsen heads for phase 3 test

Ipsen beefs up in oncology, buying US biopharma Epizyme

BioMarin gene therapy for haemophilia on course for EU approval

Autifony

Boehringer Ingelheim Center (BIC)

News/ UK & Europe

Boehringer collaborates with Autifony on schizophrenia drug

Richard Staines Autifony, Boehringer Ingelheim, European biotech, R&D, schizophrenia, UK biotech 0 Comment

Deal could be worth 627.5 million euros

X

Boehringer collaborates with Autifony on schizophrenia drug

https://pharmaphorum.com/news/boehringer-collaborates-autifony-schizophrenia-drug/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Ipsen beefs up in oncology, buying US biopharma Epizyme
Another Astellas gene therapy hits a safety hurdle
GSK hepatitis B hope bepirovirsen heads for phase 3 test
BioMarin gene therapy for haemophilia on course for EU approval
NHS England reveals travel plan to cut waiting lists

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com